2014
DOI: 10.1016/j.vaccine.2014.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Immune responses of mice against recombinant bovine herpesvirus 5 glycoprotein D

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 48 publications
0
25
0
Order By: Relevance
“…The evaluation of total IgG antibodies against BoHV-5 was performed by ELISA (Dummer et al, 2014). Briefly, plates (Nunc) were sensitized with 50µl of a suspension containing recombinant BoHV-5 glycoprotein D at a concentration of 2mg/ml diluted in carbonatebicarbonate buffer (pH 9.6) at 4ºC for 18h.…”
Section: Methodsmentioning
confidence: 99%
“…The evaluation of total IgG antibodies against BoHV-5 was performed by ELISA (Dummer et al, 2014). Briefly, plates (Nunc) were sensitized with 50µl of a suspension containing recombinant BoHV-5 glycoprotein D at a concentration of 2mg/ml diluted in carbonatebicarbonate buffer (pH 9.6) at 4ºC for 18h.…”
Section: Methodsmentioning
confidence: 99%
“…Beta-actin and GAPDH genes were used as endogenous reference controls, but subsequently, b-actin was selected as the internal reference standard based on its efficiency (M-value of 1.8 and 1.98 for GAPDH and b-actin, respectively). The primer sequence used was described elsewhere [10].…”
Section: Ex Vivo Spleen Stimulation and Cytokine Transcriptsmentioning
confidence: 99%
“…Furthermore, we expressed the secreted form of gD from BoHV-5 in P. pastoris by removing the transmembrane anchor of the native gD [ 65 ]. Recombinant BoHV-5 gD when formulated with oil-based adjuvants induced neutralizing antibodies in mice [ 25 ] and bovines (Itauá Leston Araújo, 2014 - unpublished observations) after vaccination.…”
Section: Vaccines Designed With Gdmentioning
confidence: 99%
“…In consideration of the molecular homology between these viruses [ 7 ] most of this review will describe studies with BoHV-1 and BoHV-5. However, although multiple outbreaks of infection by BoHV-5 have been described [ 22 - 24 ] and BoHV-5 infection leads to more serious disease, there are fewer reports on vaccine development strategies against BoHV-5 than against BoHV-1 [ 18 , 25 ]. Where appropriate, studies with gD from other alphaherpesviruses will be described to illustrate the recent progress with gD-based vaccines in general.…”
Section: Introductionmentioning
confidence: 99%